What are the symptoms and management of villous adenoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Villous Adenoma: Symptoms and Management

Clinical Presentation

Villous adenomas most commonly present with rectal bleeding, mucus discharge, diarrhea, and urgency, with distal lesions often causing a palpable mass on digital rectal examination.

Common Symptoms

  • Rectal bleeding is the most frequent presenting symptom 1, 2, 3
  • Mucus discharge occurs commonly, particularly with large villous adenomas due to their secretory nature 1, 2
  • Diarrhea is a characteristic symptom related to the villous architecture and mucus production 3
  • Urgency and change in bowel habits may occur, especially with larger lesions 2
  • Palpable mass on digital rectal examination, described as soft, velvety, and flat with mucus discharge 1

Less Common Presentations

  • Iron deficiency anemia from chronic occult bleeding 4
  • Abdominal pain in atypical cases 5
  • Melena with more proximal lesions 5
  • Obstruction with very large lesions 2
  • Bowel perforation (extremely rare complication) 5

Critical Risk Assessment

The malignant potential of villous adenomas is substantial and directly correlates with size, making complete resection mandatory.

Malignancy Risk Stratification

  • Villous adenomas >1 cm with villous histology are classified as "advanced adenomas" with significant malignant potential 4, 6
  • 50% of adenomatous polyps >2 cm contain foci of adenocarcinoma 4
  • Giant villous adenomas (>8 cm) carry an 83% combined risk of dysplasia/malignancy, with 50% showing dysplasia and 33% frank malignancy 1
  • Villous adenomas >2 cm have up to 50% risk of malignancy 1
  • 42% of polyps considered benign on preoperative biopsy showed malignant transformation when the entire specimen was examined 2

High-Risk Features Requiring Surgical Resection

  • Grade 3 or 4 histology 6
  • Angiolymphatic invasion 6
  • Positive margin of resection 6
  • Tumor budding 7
  • Poor tumor differentiation 7

Management Algorithm

Endoscopic Management (First-Line)

All villous adenomas should be completely removed endoscopically with en bloc resection when technically feasible.

  • Complete en bloc resection is mandatory for proper histological examination 6, 7, 8
  • Hot snare polypectomy is recommended for pedunculated lesions ≥10 mm 6, 8
  • Prophylactic mechanical ligation (detachable loop or clips) is recommended for pedunculated lesions with head ≥20 mm or stalk thickness ≥5 mm to reduce bleeding risk 6
  • Mark the polyp site at colonoscopy if cancer is suspected or within 2 weeks when pathology confirms concerning features 6
  • Document size, number, location, and completeness of removal for future surveillance planning 6, 8

Surgical Management (When Endoscopic Resection Inadequate)

Surgical resection is required for lesions too large for safe endoscopic removal or when unfavorable histopathologic features are present.

  • Laparoscopic or open segmental colectomy is indicated for giant villous adenomas not amenable to endoscopic or transanal resection 1, 2
  • Colectomy with en bloc lymph node removal is mandatory for lesions with unfavorable histology 6
  • Transanal resection may be considered for smaller distal rectal lesions, though recurrence rates are higher (26.7% vs 6.7% for segmental colectomy) 2, 9
  • Laparoscopic ultra-low anterior resection with colo-anal anastomosis is safe and effective for circumferential giant rectal villous adenomas 1

Management of Malignant Polyps

  • No additional surgery needed for completely resected pedunculated or sessile polyps with grade 1 or 2 histology, no angiolymphatic invasion, and negative resection margin 6, 8
  • Colectomy remains an option for sessile polyps even with favorable features due to 10% risk of lymph node metastases 6

Surveillance Strategy

Patients with villous adenomas require colonoscopy in 3 years due to high-risk classification.

  • 3-year surveillance interval is mandatory for villous adenomas regardless of size 6, 8
  • Multiple adenomas (≥3) or large size (≥1 cm) further increases risk, with 49% developing advanced adenoma at first follow-up 6
  • Normal surveillance colonoscopy reduces subsequent adenoma detection rate from 40% to 10% 6
  • Yearly surveillance may be appropriate for patients with multiple polyps, large size, or highest grade of dysplasia 4

Critical Pitfalls to Avoid

  • Never rely on preoperative biopsy alone to exclude malignancy—42% of "benign" biopsies showed malignancy on full pathologic examination 2
  • Incomplete polyp removal is a critical error leading to higher recurrence rates, particularly with local resection techniques 8, 2
  • Ensure high-quality baseline colonoscopy with adequate bowel preparation, complete cecal examination, and minimum 6-minute withdrawal time for accurate risk assessment 6, 8
  • Proper pathologic sectioning is essential—bisect the polyp through the center of the stalk to visualize the mucosa/submucosa junction and assess margins 7, 8
  • Synchronous neoplasia occurs in 30% of patients with adenomatous polyps, requiring careful evaluation of the entire colon 4

References

Research

Villous adenomas of the colon and rectum.

American journal of surgery, 1975

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Perforated villous adenoma of the cecum: report of a case.

Diseases of the colon and rectum, 1997

Guideline

Management and Treatment of Villous Adenoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis and Management of Pedunculated Polyps with Tubular Glands

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tubular Adenoma Management and Surveillance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.